Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions

Immunology

Volumn 130, Issue 1, 2010, Pages 34-45

  Bashir, Nasreena ^a,b,e   Kounsar, Fozia ^b   Mukhopadhyay, Sangita ^b   Hasnain, Seyed E ^a,c,d  

^a UNIVERSITY OF HYDERABAD   (India)

^b CDFD   (India)

^c Institute of Life Sciences   (India)

^d JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Innate and adaptive responses; M. tuberculosis; Rv2626c; Vaccine

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; NITRIC OXIDE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELL SURFACE; CONSERVATION BIOLOGY; CONTROLLED STUDY; EFFECTOR CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE FUNCTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL SEPARATION; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TUBERCULOSIS;

EID: 77950492841     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03196.x     Document Type: Article

References (74)

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994 271 : 698 702.
2. Kaufmann SH, MacMichael AJ. Annulling dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 2005 11 : S33 44.
3. Braun MM, Cauthen G. Relationship of the human immunodeficiency virus epidemic to pediatric tuberculosis and Bacillus Calmette-Guerin immunization. Pediatr Infect Dis J 1992 11 : 220 227.
4. von Reyn CF, Clements CJ, Mann JM. Human immunodeficiency virus infection and routine childhood immunisation. Lancet 1987 19 : 669 672.
5. Weltman AC, Rose DN. The safety of Bacilli Calmette-Guerin vaccination in HIV infection and AIDS. AIDS 1993 2 : 149 157.
6. Bosio CM, Orme IM. Effective, non-sensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice. Infect Immun 1998 66 : 5048 5051.
7. Mustafa AS. Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 2002 39 : 113 119.
8. Al-Attiyah R, Mustafa AS, Abal AT, El- Shamy AS, Dalemans W, Skeiky YA. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol 2004 138 : 139 144.
9. Kaufmann SH. Is the development of a new tuberculosis vaccine possible? Nat Med 2000 6 : 955 960.
10. Flynn JL, Ernst JD. Immune responses in tuberculosis. Curr Opin Immunol 2000 12 : 432 436.
11. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996 14 : 233 258.
12. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation requirement of B7-CD28 signaling through CD40. Science 1996 273 : 1862 1864.
13. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J Exp Med 1993 178 : 2243 2247.
14. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993 178 : 2249 2254.
15. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M. A mutation in the IFN-gamma receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996 335 : 1941 1949.
16. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989 56 : 731 740.
17. Wakeham J, Wang J, Magram J, Croitoru K, Harkness R, Dunn P, Zganiacz A, Xing Z. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J Immunol 1998 160 : 6101 6111.
18. Senaldi G, Yin S, Shaklee CL, Piguet PF, Mak TW, Ulich TR. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol 1996 157 : 5022 5026.
19. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995 2 : 561 572.
20. MacMicking JD, North RJ, La Course R et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997 94 : 5243 5248.
21. Long R, Light B, Talbot JA. Mycobacteriocidal action of exogenous nitric oxide. Antimicrob Agents Chemother 1999 43 : 403 405.
22. Chan ED, Winston BW, Uh ST, Wynes MW, Rose DM, Riches DW. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-aplha in mouse macrophages. J Immunol 1999 162 : 415 422.
23. Chan ED, Morris KR, Belisle JT, Hill P, Remigio LK, Brennan PJ, Riches DW. Induction of iNOS-NO by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways. Infect Immun 2001 69 : 2001 2010.
24. Singh G, Singh B, Trajkovic V, Sharma P. Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages. Immunol Lett 2005 98 : 180 188.
25. Trajkovic V, Singh G, Singh B, Singh S, Sharma P. Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide. Infect Immun 2002 70 : 6558 6566.
26. Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999 285 : 732 735.
27. Davidow A, Kanaujia GV, Shi L et al. Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun 2005 73 : 6846 6851.
28. Boon C, Li R, Qi R, Dick T. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J Bacteriol 2001 183 : 2672 2676.
29. Rosenkrands I, Slayden A, Crawford J, Aagaard C, Barry CE, Andersen P. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol 2002 184 : 3485 4391.
30. Shi L, Jung YJ, Tyagi S, Gennaro ML, North RJ. Expression of Th-1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of non-replicating persistence. Proc Natl Acad Sci USA 2003 100 : 241 246.
31. Roupie V, Romano M, Zhang L et al. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun 2007 75 : 941 949.
32. Leyten EM, Lin MY, Franken KL et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 2006 8 : 2052 2060.
33. Obozova TA, Artem'ev MI, Baranovski PM, Smetanina SE, Kiselev VI. Correlation between the expression of Rv3286c, Rv2626c, Rv2031c, AND Rv3133c and the tolerance of Mycobacterium bovis BCG to rifampicin and metronidazole in different hysiological conditions. Probl Tuberk Bolezn Legk 2005 2 : 34 6.
34. Prakash P, Aruna B, Sardesai AA, Hasnain SE. Purified recombinant hypothetical protein coded by open reading frame Rv1885c of Mycobacterium tuberculosis exhibits a mono functional AroQ class of periplasmic chorismate mutase activity. J Biol Chem 2005 280 : 19641 19648.
35. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988 141 : 2407 2412.
36. Khan N, Rahim SS, Boddupali CS et al. Hydrogen peroxide inhibits IL-12 p40 induction in macrophages by inhibiting c-rel translocation to the nucleus through activation of calmodulin protein. Blood 2006 107 : 1513 1520.
37. Jiang B, Haverty M, Brecher P. N-acetyl-l-cysteine enhances interleukin-1β-induced nitric oxide synthase expression. Hypertension 1999 34 : 574 579.
38. Chakhaiyar P, Nagalakshmi Y, Aruna B, Murthy KJR, Katoch VM, Hasnain SE. Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis. J Infect Dis 2004 190 : 1237 1244.
39. Tundup S, Pathak N, Ramanadham M, Mukhopadhyay S, Murthy KJ, Ehtesham NZ, Hasnain SE. The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response. PLoS ONE 2009 3 (10 e3586.
40. Morris KR, Lutz RD, Choi HS, Kamitani T, Chmura K, Chan ED. Role of the NF-kappa B signaling pathway and kappa B cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun 2003 71 : 1442 1452.
41. Torres BA, Johnson HM. Lipopolysaccharide and polyribonucleotide activation of macrophages: implications for a natural triggering signal in tumor cell killing. Biochem Biophys Res Commun 1985 131 : 395 401.
42. Mulsch A, Schray-Utz B, Mordvintcez PI, Hauschildt S, Busse R. Diethyldithiocarbamate inhibits induction of macrophage NO synthase. FEBS Lett 1993 321 : 215 218.
43. Heitmeier MR, Scarim AL, Corbett JA. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-κB activation. J Biol Chem 1998 273 : 15301 15307.
44. Bhatt K, Hickman SP, Salgame P. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J Immunol 2004 172 : 2748 2751.
45. Lazarevic V, Myers AJ, Scanga CA, Flynn JL. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol Mycobacterium tuberculosis infection. Immunity 2003 19 : 823 835.
46. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001 19 : 93 129.
47. Dannenberg AM Jr. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991 12 : 228 233.
48. Barnes PF, Modlin RL. Human cellular immune responses to Mycobacterium tuberculosis. Curr Top Microbiol Immunol 1996 215 : 197 219.
49. Orme IM, Anderson P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993 167 : 1481 1497.
50. Koga T, Mitsuyama M, Watanabe Y, Yamada A, Yoshikai Y, Nomoto K. Effect of increase in macrophage Ia expression on subsequent immune response in vivo. J Clin Lab Immunol 1986 20 : 29 35.
51. Miyata M, Mitsuyama M, Ogata N, Nomoto K, Takeya K. Two steps in the generation of acquired cellular resistance against Listeria monocytogenes: accumulation and activation of macrophages. Immunology 1982 47 : 247 253.
52. Munn DH, Pressey J, Beall AC, Hudes R, Alderson MR. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion. J Immunol 1996 156 : 523 532.
53. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC. Macrophage-T cell interaction in experimental mycobacterial infection-selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur J Immunol 1994 24 : 2618 2624.
54. Kumar V, Bhardwaj V, Soares L, Alexander J, Sette A, Sercarz E. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon by T cells. Proc Natl Acad Sci USA 1995 92 : 9510 9514.
55. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995 181 : 1569 1574.
56. Chaturvedi P, Yu Q, Southwood S, Sette A, Singh B. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int Immunol 1996 8 : 745 755.
57. Singh N, Bhatia S, Abraham R, Basu SK, George A, Bal V, Rath S. Modulation of T cell cytokine profiles and peptide-MHC complex availability in vivo by delivery to scavenger receptors via antigen-maleylation. J Immunol 1998 160 : 4869 4880.
58. Trinchieri G. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994 84 : 4008 4027.
59. Magram J, Connaughton SE, Warrier RR et al. IL-12-deficient mice are defective in IFN- γ production and type 1 cytokine responses. Immunity 1996 4 : 471 481. (Pubitemid 26354656)
60. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993 178 : 1041 1048.
61. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE Interleukin-10. Curr Opin Immunol 1992 4 : 314 320.
62. Basu S, Pathak SK, Banerjee A et al. Execution of macrophage apoptosis by PE-PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J Biol Chem 2007 282 : 1039 1050.
63. Khan N, Ghousunnissa S, Jegadeeswaran SM, Thiagarajan D, Hasnain SE, Mukhopadhyay S. Anti-B7-1/B7-2 antibody elicits innate-effector responses in macrophages through NF-kappaB-dependent pathway. Int Immunol 2007 19 : 477 486.
64. Xiong H, Zhu C, Li F, Hegazi R, He K, Babyatsky M, Bauer AJ, Plevy SE. Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. J Biol Chem 2004 279 : 10776 10783.
65. Mukhopadhyay S, Nair S, Hasnain SE. Nitric oxide: friendly rivalry. Curr Signal Transduct Ther 2007 2 : 1 9.
66. Fang FC. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997 99 : 2818 2825.
67. Gomes SM, Florido M, Pais FT, Appelberg R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 1999 162 : 6734 6739.
68. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002 15 : 294 309.
69. Tanghe A, Denis O, Lambrecht B, Motte V, van den Berg T, Huygen K. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect Immun 2000 68 : 3854 3860.
70. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000 97 : 13853 13858.
71. Brandt L, Skeiky YA, Alderson MR et al. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect Immun 2004 72 : 6622 6632.
72. Kumar P, Amara RR, Challu VK, Chadda VK, Satchidanandam V. The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect Immun 2003 71 : 1929 1937.
73. Xu J, Xu W, Chen X, Zhao D, Wang Y. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. Vaccine 2008 26 : 4519 4525.
74. Wu J, Xu J, Cai C, Gao X, Li L, Zhong N. Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma. Respir Res 2009 10 : 51.